Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheRapport
Europol ; L. LANIEL ; C. CARPENTIER ; J. MOUNTENEY ; B. PALLAVICINI ; L. ROYUELA ; J. MATIAS ; R. KASECKER ; R. SEDEFOV ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : L'OEDT et Europol publient une analyse conjointe concernant le marché des amphétamines. Leader dans la production des amphétamines, l'Europe est également une zone importante de consommation. ENGLISH: This joint publication with [...]Article : Périodique
G. MENA ; I. GIRAUDON ; E. ALVAREZ ; J. M. CORKERY ; J. MATIAS ; K. GRASAASEN ; N. LLORENS ; P. GRIFFITHS ; J. VICENTE |Background: Cocaine-related health consequences are difficult to observe. Data on drug users in health-emergency settings may be a useful source of information on consequences that are not visible via other information sources. Methods: Thirty[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; J. MATIAS ; L. MONTANARI ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug use, in particular high-risk drug use, is one of the major causes of avoidable mortality among young people in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence and suicide. The Drug-r[...]Rapport
The protocol establishes harmonised criteria to extract process and report cases, based on the information available, at the end point of the chain of certification/ascertainment procedures, at different mortality registries: General Mortality R[...]Périodique
OEDT = EMCDDA ; I. GIRAUDON ; G. MENA ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014This study reveals the substantial levels of morbidity related to cocaine use, translated into the large number of cocaine cases seen in various emergency settings in European countries. This health burden is often not captured by other traditio[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2017This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]Chapitre
L. VANDAM ; J. MATIAS ; R. McKETIN ; M. MEACHAM ; P. GRIFFITHS ; S. R. QUAH | Oxford : Academic Press | 2017Rapport
OEDT = EMCDDA ; I. GIRAUDON ; M. BUSTER ; A. ESPELT ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2015This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries to drug treatment records. Building on earlier w[...]Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA |This paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]Article : Périodique
D. OLSZEWSKI ; J. MATIAS ; K. MONSHOUWER ; A. KOKKEVI |Aims: We describe types of polydrug use among school students across Europe and explore differences between high, medium and low drug prevalence countries. Method: Analysis is based on survey data from over 70,000 15- to 16-year-old school stud[...]Rapport
OEDT = EMCDDA ; D. THANKI ; J. MATIAS ; P. GRIFFITHS ; A. NOOR ; D. OLSZEWSKI ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported da[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2016This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]Chapitre
Les usages de substances en Europe sont inégalement répartis selon les territoires et concernent souvent les jeunes générations. C'est particulièrement vrai à propos du cannabis et des substances stimulantes et hallucinogènes (les opiacés étant [...]
